[Central serous corticoid and chorioretinopathy].

Area of Science:

• Ophthalmology
• Endocrinology

Background:

• Central serous chorioretinopathy (CSC) is a common eye condition with unclear causes.
• CSC often affects young men, particularly those with Type A personalities under stress.
• Recent findings link hypercortisolism (high cortisol) to CSC development and worsening.

Purpose of the Study:

• To explore the association between hypercortisolism and central serous chorioretinopathy.
• To investigate the role of endogenous and exogenous cortisol in CSC.
• To evaluate the contraindication of glucocorticoids in CSC management.

Main Methods:

• Review of clinical features and patient history related to CSC.
• Analysis of cases involving endogenous or exogenous hypercortisolism.
• Examination of the impact of glucocorticoid administration on CSC.

Main Results:

• Endogenous and exogenous hypercortisolism are associated with CSC.
• Various administration routes (IV, cutaneous, nasal spray) of exogenous cortisol can induce or worsen CSC.
• Clinical signs like bilateral lesions and atypical presentations may suggest a link to hypercortisolism.

Conclusions:

• Hypercortisolism is a significant factor in the pathophysiology of CSC.
• Glucocorticoids, previously used in treatment, are now considered contraindicated for CSC.
• Further research is needed to fully elucidate the mechanisms and optimize CSC management.